Background mRNA COVID-19 vaccines have been associated with myocarditis in the
general population. However, application of gold standard techniques is often missing, and …

Since June 2021, cases of myocarditis after the BNT162b2 vaccine (Pfizer/BioNTech) have
been reported, mainly in young men after the second dose of the vaccine. 1 A report from …

Myocarditis is an inflammatory cardiomyopathy, most frequently caused by viral agents,
affecting 10-20 individuals per 100.000 each year in the general population [1]. Myocarditis …

SARS-CoV-2 vaccine–associated myocarditis/myocardial injury should be evaluated in the
contexts of COVID-19 infection, other types of viral myocarditis, and other vaccine …

Introduction Myocarditis has been reported following the second dose of COVID-19 mRNA
vaccination. Whether administration of additional doses of COVID-19 vaccines further …

Importance Myocarditis has been reported with COVID-19 but is not clearly recognized as a
possible adverse event following COVID-19 vaccination. Objective To describe myocarditis …

Background Post-marketing surveillance studies have raised concerns of increased
myocarditis rates following coronavirus disease-19 (Covid-19) mRNA vaccines. The present …

Background: Recent surveillance studies following nationwide mass vaccination are
investigating rare complications such as myocarditis, pericarditis, and thromboembolic …

The risk of acute myocarditis associated with COVID-19 mRNA vaccination has garnered
intense (social) media attention. However, myocarditis after COVID-19 mRNA vaccination is …

COVID-19 vaccine-related myocarditis has been reported worldwide. We herein report two
Japanese cases with suspected vaccine-related myocarditis. A 27-year-old man was …